Клиническая онкогематология. Фундаментальные исследования и клиническая практика
Clinical Oncohematology. Basic Research and Clinical Practice
ISSN 1997-6933 (print)
ISSN 2500-2139 (online)
Русский English
  • Register
  • Login
Skip to main content Skip to main navigation menu Skip to site footer
Clinical Oncohematology
Basic Research and Clinical Practice

ИФ РИНЦ:     0,587
H-INDEX:        16

  • Home
  • About the Journal
    • Aims and Scope
    • Editorial Board
    • Peer Review
    • Publishing Ethics and Malpractice Statement
    • Indexing and Abstracting
    • Ownership, management and funding
    • Open Access Policy and Publication Fee
  • Articles
    • Current
    • Journal pre-proofs
    • Archive
    • SUPPLEMENT
  • Sections
    • LYMPHOID TUMORS
    • MYELOID TUMORS
    • BONE MARROW TRANSPLANTATION
    • ANEMIAS
    • AUTOIMMUNE DISEASES
    • CLINICAL TRIALS
    • NOVEL CORONAVIRUS INFECTION
    • NEWS
    • NEW TECHNOLOGIES
    • REVIEWS
    • COMPLICATIONS OF CHEMOTHERAPY
    • PRACTICAL RECOMMENDATIONS
    • RARE HEMATOLOGICAL TUMORS AND SYNDROMES
    • EXPERIMENTAL STUDIES
  • Submission
  • Register
  • Login
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Plasmablastic Lymphoma in HIV-Positive Patients: A Literature Review and Results of a Russian Multi-Center Retrospective Study

    Marina Olegovna Popova, I.V. Tsygankov, Ya.V. Gudozhnikova, Yu.A. Rogacheva, N.P. Volkov, K.V. Lepik, M.V. Demchenkova, M.V. Grigoreva, A.Yu. Efirkina, T.V. Shneider, Yu.V. Kopeikina, S.A. Stepanova, V.G. Potapenko, A.V. Klimovich, N.V. Medvedeva, M.A. Kolesnikova, T.I. Pospelova, N.B. Mikhailova, V.V. Baikov, A.D. Kulagin
    28-41
    01.01.2022
  • A Rationale for a New Operational Integrated Quality and Efficiency Index for Assessing the Performance of Hematological Services in Constituent Entities of the Russian Federation

    Elena Nikolaevna Parovichnikova, T.Ts. Garmaeva, O.V. Lazareva, K.A. Lukina, Yu.A. Chabaeva, S.M. Kulikov, V.V. Troitskaya, T.V. Gaponova, L.I. Menshikova, V.G. Savchenko
    1-15
    01.01.2022
  • The Efficacy of Brentuximab Vedotin in Relapsed/Refractory Classical Hodgkin’s Lymphoma and Quality of Life: Results of a Multi-Center Observational Prospective Study in the Context of Real Clinical Practice

    T.I. Ionova, A.A. Amdiev, M.I. Andrievskikh, E.A. Baryakh, E.V. Vasilev, M.V. Volkov, E.M. Volodicheva, V.V. Ivanov, O.V. Kaverina, K.D. Kaplanov, T.Yu. Klitochenko, V.I. Kurakin, D.G. Lazareva, O.G. Larionova, K.V. Lepik, I.B. Lysenko, V.Ya. Melnichenko, R.I. Minullina, O.V. Mironov, E.N. Misyurina, N.B. Mikhailova, N.E. Mochkin, Tatyana Pavlovna Nikitina, T.S. Petrova, N.M. Porfireva, O.A. Rukavitsyn, A.A. Samoilova, R.N. Safin, P.I. Simashova, E.G. Smirnova, N.A. Trenina, N.V. Fadeeva, G.N. Khusainova, V.L. Chang, T.V. Shelekhova, D.G. Sherstnev
    42-53
    01.01.2022
  • Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma with Renal Impairment

    Maiya Valerevna Firsova, L.P. Mendeleeva, M.V. Solov’ev, D.A. Mironova, L.A. Kuzmina, V.G. Savchenko
    97-106
    01.01.2022
  • Ibrutinib as First-Line Therapy in High-Risk Chronic Lymphocytic Leukemia: Case Reports

    Nadezhda Viktorovna Kurkina, E.A. Repina
    488-495
    01.10.2021
  • Carmustine in the Therapy of B-Cell Lymphomas

    Daria Aleksandrovna Koroleva, E.E. Zvonkov
    496-502
    01.10.2021
  • Acute Myeloid Leukemia Patient-Derived Xenograft Models Generated with the Use of Immunodeficient NSG-SGM3 Mice

    Ekaterina Viktorovna Baidyuk, E.V. Belotserkovskaya, L.L. Girshova, V.A. Golotin, K.A. Levchuk, M.L. Vasyutina, Ya.A. Portnaya, E.V. Shchelina, O.G. Bredneva, A.V. Petukhov, A.Yu. Zaritskey, O.N. Demidov
    414-425
    01.10.2021
  • Prediction of Treatment Efficacy in Relapsed Chronic Lymphocytic Leukemia

    Olga Borisovna Kalashnikova, I.S. Moiseev, T.L. Gindina, E.A. Izmailova, M.O. Ivanova, E.V. Kondakova, N.B. Mikhailova, A.D. Kulagin
    466-476
    01.10.2021
  • Efficacy, Safety, and Tolerance of Gemtuzumab Ozogamicin Combined with FLAG/FLAG-Ida or Azacitidine in Relapsed/Refractory Acute Myeloblastic Leukemia

    Irina Garmaevna Budaeva, D.V. Zaitsev, A.A. Shatilova, E.N. Tochenaya, A.V. Petrov, R.I. Vabishchevich, D.V. Motorin, R.Sh. Badaev, D.B. Zammoeva, V.V. Ivanov, S.V. Efremova, K.V. Bogdanov, Yu.V. Mirolyubova, T.S. Nikulina, Yu.A. Alekseeva, A.Yu. Zaritskey, L.L. Girshova
    299-307
    01.07.2021
  • Pharmacoeconomic Analysis of R-DA-EPOCH and R-mNHL-BFM-90 Combination Immunochemotherapy in Patients with Prognostically Unfavorable Diffuse Large B-Cell Lymphoma within Randomized Multi-Center Clinical Trial DLBCL-2015

    Madina Olegovna Bagova, A.U. Magomedova, S.K. Kravchenko, R.I. Yagudina, V.G. Serpik, S.M. Kulikov, Yu.A. Chabaeva
    321-332
    01.07.2021
  • Multiple Myeloma and Dendritic Cell Vaccines

    Irina Vladimirovna Gribkova, A.A. Zavyalov
    370-377
    01.07.2021
  • Value of PD-L1 Protein Expression in the Combined Prognostic Model of Diffuse Large B-Cell Lymphoma

    Svetlana Valerevna Samarina, N.Yu. Semenova, N.V. Minaeva, D.A. Dyakonov, V.A. Rosin, E.V. Vaneeva, S.V. Gritsaev
    308-314
    01.07.2021
  • Potential Predictors and Response Quality after Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma

    Ivan Ivanovich Kostroma, Zh.Yu. Sidorova, N.Yu. Semenova, A.A. Zhernyakova, R.R. Sabitova, S.P. Svitina, E.I. Stepchenkova, S.S. Bessmeltsev, A.V. Chechetkin, S.V. Gritsaev
    333-339
    01.07.2021
  • Polymorphism of Interleukins and Tumor Necrosis Factor α Genes in Multiple Myeloma Patients with Autologous Hematopoietic Stem Cell Transplantation

    Svetlana Pavlovna Svitina, Zh.Yu. Sidorova, I.I. Kostroma, A.A. Zhernyakova, A.V. Chechetkin, Zh.V. Chubukina, S.V. Gritsaev, S.I. Kapustin, S.S. Bessmeltsev
    340-346
    01.07.2021
  • Current Issues of Targeted Therapy of Polycythemia Vera

    Anait Levonovna Melikyan, I.N. Subortseva
    355-360
    01.07.2021
  • Stable Chronology of Granulopoiesis under R(G)-DHAP Immunochemotherapy-Induced Cytotoxic Stress in Non-Hodgkin’s Lymphomas

    Kseniya Andreevna Sychevskaya, S.K. Kravchenko, F.E. Babaeva, A.E. Misyurina, A.M. Kremenetskaya, A.I. Vorob’ev
    204-219
    01.04.2021
  • CAR-Т Cells for the Treatment of Chronic Lymphocytic Leukemia: Literature Review

    Irina Vladimirovna Gribkova, A.A. Zav’yalov
    225-230
    01.04.2021
  • Cardio-oncology and Oncohematology: Examination Algorithms, Prophylactic and Treatment of Cardiotoxicity, Trends in Rehabilitation

    Elena Ivanovna Emelina, G.E. Gendlin, I.G. Nikitin
    239-261
    01.04.2021
  • National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2020)

    Anait Levonovna Melikyan, A.M. Kovrigina, I.N. Subortseva, V.A Shuvaev, E.V. Morozova, E.G. Lomaia, B.V. Afanasyev, T.A. Ageeva, V.V. Baikov, O.Yu. Vinogradova, S.V. Gritsaev, A.Yu. Zaritskey, T.I. Ionova, K.D. Kaplanov, I.S. Martynkevich, T.A. Mitina, E.S. Polushkina, T.I. Pospelova, M.A. Sokolova, A.B. Sudarikov, A.G. Turkina, Yu.V. Shatokhin, R.G. Shmakov, V.G. Savchenko
    262-298
    01.04.2021
  • Checkpoint Inhibitors and Classical Hodgkin’s Lymphoma: Efficacy and Safety of Pembrolizumab in Relapsed/Refractory Tumor (Experience at the NI Pirogov Russian National Medical Center of Surgery)

    Vladislav Olegovich Sarzhevskii, E.A. Demina, N.E. Mochkin, A.A. Spornik, A.A. Mamedova, E.G. Smirnova, A.E. Bannikova, A.A. Samoilova, V.S. Bogatyrev, V.Ya. Melnichenko
    53-62
    01.01.2021
  • Comparative Analysis of Myelofibrosis Treatment Outcomes with the Use of Ruxolitinib Versus Ruxolitinib with Subsequent Allogeneic Hematopoietic Stem Cell Transplantation

    Mariya Vladimirovna Barabanshchikova, E.V. Morozova, Yu.Yu. Vlasova, T.L. Gindina, A.V. Evdokimov, I.M. Barkhatov, V.V. Baikov, I.O. Ivanova, T.A. Rudakova, E.A. Bakin, I.S. Moiseev, A.D. Kulagin
    22-30
    01.01.2021
  • Chronic Lymphocytic Leukemia in Blood Relatives: Two Case Reports of Male Siblings

    Nadezhda Viktorovna Kurkina, E.A. Repina
    69-72
    01.01.2021
  • Opportunities of Chronic Myeloid Leukemia Treatment with Reduced Doses of Tyrosine Kinase Inhibitors

    Margarita Anatolevna Guryanova, E.Yu. Chelysheva, A.G. Turkina
    118-128
    01.01.2021
  • Successful Treatment of Aplastic Anemia in the Kyrgyz Republic

    Sagynali Murzaevich Mamatov, E.M. Sadabaev, O.A. Dzhakypbaev, M.O. Eralieva
    406-410
    01.10.2020
  • Intermediate Results of Prospective, Randomized, Comparative Study of NHL BFM-90 and СНОЕР Efficacy in Primary ALK-Positive Anaplastic Large-Cell Lymphoma

    Liliya Gamilevna Gorenkova, S.K. Kravchenko, E.E. Klebanova, A.M. Kovrigina, K.A. Sychevskaya, E.G. Gemdzhian, E.S. Nesterova, Ya.K. Mangasarova, A.V. Misyurin, Yu.V. Sidorova, T.N. Obukhova
    382-388
    01.10.2020
  • Long-Term Outcomes of Nivolumab Therapy in Patients with Relapsed/Refractory Classic Hodgkin’s Lymphoma after High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Real Clinical Practice

    Kirill Viktorovich Lepik, N.P. Volkov, N.B. Mikhailova, E.V. Kondakova, L.A. Tsvetkova, Yu.R. Zalyalov, E.E. Lepik, L.V. Fedorova, A.V. Beinarovich, M.V. Demchenkova, O.G. Smykova, P.V. Kotselyabina, I.S. Moiseev, V.V. Baikov, B.V. Afanasyev
    280-288
    01.07.2020
  • Comorbidity and Personalized Treatment of Multiple Myeloma in Real Clinical Practice

    Nataliya Valer’evna Skvortsova, I.B. Kovynev, K.V. Khalzov, T.I. Pospelova, I.N. Nechunaeva
    322-334
    01.07.2020
  • Early Response and Long-Term Outcomes of Ruxolitinib Therapy in Myelofibrosis: Multicenter Retrospective Study in 10 Centers of the Russian Federation

    E.G. Lomaia, Nadiya Tamazovna Siordiya, O.M. Senderova, O.E. Ochirova, E.B. Zhalsanova, A.Yu. Furtovskaya, G.P. Dimov, M. G. Pozina, O.Yu. Li, K.B. Trizna, M.A. Mikhalev, E.V. Sokurova, A.A. Otmorskaya, A.S. Khazieva, V.V. Ust’yantseva, Yu.D. Rogovaya, A.Yu. Zaritskey
    335-345
    01.07.2020
  • Safety and Efficacy of BeEAC as a Conditioning Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Lymphomas

    V.O. Sarzhevskii, Anastasiya Aleksandrovna Samoilova, V.Ya. Melnichenko, Yu.N. Dubinina, N.E. Mochkin, D.S. Kolesnikova, D.A. Fedorenko, E.G. Smirnova, A.E. Bannikova, V.S. Bogatyrev
    185-192
    01.04.2020
  • Bendamustine in the Treatment of Relapsed/Refractory Hodgkin’s Lymphoma: Literature Review and Clinical Experience

    Stanislav Sergeevich Shklyaev, N.A. Falaleeva, T.I. Bogatyreva, A.Yu. Terekhova, M.A. Danilova
    136-149
    01.04.2020
  • Diagnosis and Treatment of Clonal Myeloproliferative Neoplasms with Eosinophilia

    Irina Semenovna Nemchenko, N.N. Tsyba, A.G. Turkina, E.Yu. Chelysheva, O.A. Shukhov, A.M. Kovrigina, T.N. Obukhova
    161-169
    01.04.2020
  • Granulocyte-Macrophage Colony-Stimulating Factor and CAR-T Technology for Solid Tumors in Experiment

    Daniil Vladislavovich Zaytsev, E.K. Zaikova, A.S. Golovkin, E.R. Bulatov, A.Kh. Valiullina, R.M. Mirgayazova, A.A. Daks, A.Yu. Zaritskey, A.V. Petukhov
    115-122
    01.04.2020
  • Primary Bone Lymphomas: 18F-FDG PET and PET-CT as Methods of Diagnosis and Efficacy Estimation of Antitumor Treatment

    Anna Konstantinovna Smol’yaninova, E.R. Moskalets, G.A. Yatsyk, I.E. Kostina, A.S. Bogolyubskaya, N.G. Gabeeva, E.G. Gemdzhian, S.A. Tatarnikova, D.S. Badmadzhapova, E.E. Zvonkov
    33-49
    01.01.2020
  • Clinical Efficacy of Daratumumab in Monotherapy of Relapsed/Refractory Multiple Myeloma

    Stanislav Semenovich Bessmeltsev, E.V. Karyagina, E.Yu. Ilyushkina, Zh.L. Stolypina, R.R. Miftakhova, I.I. Kostroma, T.L. Shelkovskaya
    25-32
    01.01.2020
  • Hodgkin’s Lymphoma: Analysis Results of Volgograd Regional Registry

    Kamil Daniyalovich Kaplanov, N.P. Volkov, T.Yu. Klitochenko, I.V. Matveeva, A.L. Shipaeva, M.N. Shirokova, N.V. Davydova, E.G. Gemdzhian
    363-376
    01.10.2019
  • Experience with the Use of Thio/Mel Conditioning Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma

    S.V. Gritsaev, Ivan Ivanovich Kostroma, A.A. Zhernyakova, I.M. Zapreeva, E.V. Karyagina, Zh.V. Chubukina, S.A. Tiranova, I.S. Martynkevich, S.S. Bessmeltsev, A.V. Chechetkin
    282-288
    01.07.2019
  • WT1 Gene Overexpression in Differential Diagnosis of Ph-negative Myeloproliferative Disorders

    E.G. Lomaia, Nadiya Tamazovna Siordiya, E.G. Lisina, O.M. Senderova, A.A. Silyutina, A.Yu. Zaritskey
    297-302
    01.07.2019
  • Clinical Value of miR-3151 Overexpression in Synergistic Interaction with BAALC Host Gene in Patients with Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

    Alena Igorevna Shakirova, I.M. Barkhatov, A.I. Churkina, N.N. Mamaev, L.S. Zubarovskaya, B.V. Afanas’ev
    303-308
    01.07.2019
  • Paroxysmal Nocturnal Hemoglobinuria in Patients with Aplastic Anemia: Challenges, Characteristics, and Analysis of Clinical Experience

    Elena Romanovna Shilova, T.V. Glazanova, Zh.V. Chubukina, O.E. Rozanova, M.N. Zenina, A.V. Seltser, V.I. Rugal, V.A. Balashova, V.A. Kobilyanskaya, I.I. Krobinets, V.Yu. Udal’eva, I.I. Zotova, L.V. Stelmashenko, N.A. Romanenko, T.B. Zamotina, I.V. Khorsheva, S.V. Voloshin
    319-328
    01.07.2019
  • Primary Bone Lymphomas: Long-Term Results of a Prospective Single-Center Trial

    Anna Konstantinovna Smol’yaninova, N.G. Gabeeva, V.E. Mamonov, S.A. Tatarnikova, L.G. Gorenkova, D.S. Badmadzhapova, A.M. Kovrigina, E.G. Gemdzhian, E.E. Zvonkov
    247-262
    01.07.2019
81 - 120 of 201 items << < 1 2 3 4 5 6 > >> 

oa-antiplagiat

Антиплагиат

Make a Submission

Make a Submission

Banner ROHS

Russian Oncohematology Society

Indexing Databases

  • ISSN
  • cyberleninka cyberleninka
  • DOAJ
  • Web of Science
  • Scopus
  • Elsevier
  • CAS Source Index (CASSI)
  • NLM Catalog
  • British Library
  • РИНЦ
  • Science Index
  • SCImago
  • The European Library
  • Scholia
  • Journal Observatory
  • Scholar Google
  • IPR Smart
  • RSL
  • Ulrich's Serials Analysis System
  • ВИНИТИ
  • WorldCat
  • Research4Life
  • Lens
  • Mendeley
  • MIAR
  • OpenCitations
  • xueshu
  • OpenAlex
  • Scilit
  • Wikidata
  • na.neicon
  • Internet Archive scholar
  • ZDB catalogue
  • Keepers ISSN
  • RusMed
  • RCSI

Editor-in-Chief

Gayane Sepugovna Tumyan

ARCHIVE

2026
  • Issue 1 (2026)
  • Issue 2 (2026)
  • Issue 3 (2026)
2025
  • Issue 1 (2025)
  • Issue 2 (2025)
  • Issue 3 (2025)
  • Issue 4 (2025)
2024
  • Issue 1 (2024)
  • Issue 2 (2024)
  • Issue 3 (2024)
  • Issue 4 (2024)
2023
  • Issue 1 (2023)
  • Issue 2 (2023)
  • Issue 3 (2023)
  • Issue 4 (2023)
2022
  • Issue 1 (2022)
  • Issue 2 (2022)
  • Issue 3 (2022)
  • Issue 4 (2022)
2021
  • Issue 1 (2021)
  • Issue 2 (2021)
  • Issue 3 (2021)
  • Issue 4 (2021)
2020
  • Issue 1 (2020)
  • Issue 2 (2020)
  • Issue 3 (2020)
  • Issue 4 (2020)
2019
  • Issue 1 (2019)
  • Issue 2 (2019)
  • Issue 3 (2019)
  • Issue 4 (2019)
2018
  • Issue 1 (2018)
  • Issue 2 (2018)
  • Issue 3 (2018)
  • Issue 4 (2018)
2017
  • Issue 1 (2017)
  • Issue 2 (2017)
  • Issue 3 (2017)
  • Issue 4 (2017)
2016
  • Issue 1 (2016)
  • Issue 2 (2016)
  • Issue 3 (2016)
  • Issue 4 (2016)
2015
  • Issue 1 (2015)
  • Issue 2 (2015)
  • Issue 3 (2015)
  • Issue 4 (2015)
2014
  • Issue 1 (2014)
  • Issue 2 (2014)
  • Issue 3 (2014)
  • Issue 4 (2014)
2013
  • Issue 1 (2013)
  • Issue 2 (2013)
  • Issue 3 (2013)
  • Issue 4 (2013)
ALL ARCHIVE

Keywords

Most Read Articles
  • National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2024)
    354
  • Obinutuzumab-Based Regimens in the First-Line Therapy for Follicular Lymphoma: Data from Real-World Clinical Practice in 41 Medical Institutions
    312
  • National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2020)
    288
  • Current Quality-of-Life Aspects in Patients with Classical Ph-Negative Myeloproliferative Neoplasms in the Russian Federation: Results and Discussion of the National Observational Program MPN-QoL-2020
    279
  • Ponatinib Efficacy in Chronic Phase Chronic Myeloid Leukemia: Data from Three Centers in the Russian Federation
    248
  • Efficacy and Safety of Glofitamab Therapy in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A United Russian Experience Based on the Compassionate Use Program
    211
  • Diagnostic Value of 18F-FDG PET/CT for Detecting Bone Marrow Tumor Lesions in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma
    199
  • Conditioning Regimens Prior to Autologous Hematopoietic Stem Cell Transplantation in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma
    194
  • Gilteritinib for Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia: from Biology to Clinical Practice (Experience of the AF Tsyb Medical Radiological Research Center)
    192
  • T-Cell Clonality Analysis in the Diagnosis of Cutaneous Lymphomas: Comparative Efficacy of Methods
    133

Partners

Roche
Novartis Pharma
AstraZeneca
AbbVie
Swedish Orphan Biovitrum / SOBI
Roche
Novartis Pharma
AstraZeneca
AbbVie
Swedish Orphan Biovitrum / SOBI

«PRACTICAL MEDICINE» LLC
115201, Moscow, 1st Kotlyakovsky Pereulok 3
Phone. +7 (495) 324-93-29
E-mail: org@bloodjournal.ru
medprint.ru


Copyright © Clinical Oncohematology. Basic Research and Clinical Practice 2026

Up